How we are
different
We have created a premier AI-Powered Pharma Tech and Services fund for early-stage companies. Pharma Tech is the evolutionary progression of healthcare software and tech-enabled services to vastly improve time to market and effectiveness within the Pharmaceutical industry.
An interdisciplinary team identifying highly valued Pharma Tech companies in a shortened time frame to a sale, while maximizing investment return
Focused sector strategy
We invest exclusively in Pharma Tech, B2B SaaS and tech-enabled services with capital-efficient models built to scale. We don’t dabble outside our circle.
Operator-investor DNA
Our team has launched, financed, scaled, and exited Pharma Tech companies. We bring that operating experience to every portfolio company, hands-on.
Proprietary deal engine
Two decades operating in Pharma Tech and SaaS services has built a sourcing pipeline competitors can’t replicate.
Lead and co-lead positioning
We invest at seed and Series A with initial checks of $500K–$2M, typically leading or co-leading the round, setting terms, and taking a board seat to drive value from day one.
Strategic investor network
Our investors are pharma, provider, and payer decision-makers, your potential customers and acquirers, turning network access into commercial traction and exit pathways.
Hands-on company building
Roll-up-your-sleeves operational support: go-to-market, BD, financing, hiring, governance. We compress the time from inception to scale to sale.
Asymmetric moves in a crowded sector
Most healthcare investors spread bets across delivery, payers, and biotech. We don’t. By concentrating exclusively on Pharma Tech, we back the founders whose moats compound fastest.